REFERENCES
- Imada T, Miyazaki S, Nishida M, Yamaguchi K, Goto S. In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116. Antimicrob Agents Chemother 1992; 36: 573–9.
- Neu HC, Fang W, Gu J-W, Chin N-X. In vitro activity of OPC-17116. Antimicrob Agents Chemother 1992; 36: 1310-15.
- Sader HS, Erwin ME, Jones RN. In vitro activity of OPC-17116 compared to other broad-spectrum fluoro-quinolones. Eur J Clin Microbiol Infect Dis 1992; 11: 372–81.
- Wakebe H, Mitsuhashi S. Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria. Antimicrob Agents Chemother 1992; 36: 2185-91.
- National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 3rd edn; Approved Standard M7-A3, Wayne PA: National Committee for Clinical Laboratory Standards 1993.
- National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 3rd edn; Approved Standard M11-A3, Wayne, PA: National Committee for Clinical Laboratory Standards 1993.
- Barry AL, Fuchs PC, Jones RN, The Collaborative Antimicrobial Susceptibility Testing Group. Statistical criteria for selected quality control limits for broth microdilution sus-ceptibility tests with 39 different antimicrobial agents. Diagn Microbiol Infect Dis 1989; 12: 413–420.
- Sewell DL, Barry AL, Allen SD, Fuchs PC, Jorgensen JH, Tenover FC. Tentative criteria for determining the in vitro susceptibility of Haemophilus influenzae, including qual-ity control parameters, to two fluoroquinolones (grepafloxacin and PD131628). Diagn Microbiol Infect Dis 1995; 21: 175–179.
- National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Susceptibility Testing; Sixth Informational Supplement M100-56, Wayne, PA: National Committee for Clinical Laboratory Standards 1995.
- National Committee for Clinical Laboratory Standards. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Tentative Guideline M 26-T, Wayne PA: National Committee for Clinical Laboratory Standards 1992.
- Pearson RD, Steigbigel RT, Davis HT, Chapman SW. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother 1980; 18: 699–708.
- Barry AL. In vitro activity of the quinolones and related compounds. In: Siporin C, Heifetz CL, Donagala LM, eds. The New Generation of Quinolones. New York: Marcel Dekker, 1990: 79–105.
- Wadsworth SJ, Kim K-H, Satishchandran V, Axelrod P, Truant AL, Suh B. Development of new antibiotic resis-tance in methicillin-resistant but not methicillin-susceptible Staphylococcus aureus. J Antimicrob Chemother 1992; 30: 821–6.